Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer

NCT07233863 is registered in ClinicalTrials.gov with Dharmais National Cancer Center Hospital as lead sponsor.

NCT NCT07233863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07233863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer
Lead sponsor
Dharmais National Cancer Center Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 18, 2024
Completion date
March 21, 2028
Enrollment
136 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphedema arm